D-0188-2025 Class II Ongoing
Recall Details
- Product Type
- Drugs
- Report Date
- January 15, 2025
- Initiation Date
- December 30, 2024
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 42,527 bottles
Product Description
Duloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30) and b) 1000 count (NDC 57237-018-99) bottles, Rx only, Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ
Reason for Recall
CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.
Distribution Pattern
Nationwide
Code Information
a) Lot# DT3023051A, exp. date Apr-25; b) DT3023025A, exp. date Jan-25